R. Perroncel

Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents.

A. Anzueto, M. Niederman, S. Sethi, 2006, Respiratory medicine.

Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis

M. Miravitlles, P. Arvis, S. Choudhri, 2011, European Respiratory Journal.

Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis

H. Ariza, R. Rojas, J. Herrington, 2006, BMC Ear, Nose and Throat Disorders.

Complicated Urinary Tract Infections Treated with Extended-Release Ciprofloxacin with Emphasis on Pseudomonas aeruginosa

D. Haverstock, J. Herrington, A. Benson, 2007, Journal of chemotherapy.

PROSPECTIVE, RANDOMIZED, COMPARATIVE TRIAL OF CIPROFLOXACIN OTIC DROPS, WITH OR WITHOUT HYDROCORTISONE, VS. POLYMYXIN B-NEOMYCIN-HYDROCORTISONE OTIC S USPENSION IN THE TREATMENT OF ACUTE DIFFUSE OTITIS EXTERNA

T. Bock, F. Lucente, M. Drehobl, 1999 .

Comparison of a 3‐day with a 1‐day regimen of an extended‐release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate

F. Montorsi, A. Schaeffer, V. Scattoni, 2007, BJU international.

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.

R. Echols, J. Kanga, J. Stevens, 1997, The Pediatric infectious disease journal.